speb/financial-data huggingface dataset:
BDTX income_statement (annual, 2023-12-31) — Diluted EPS: -1.88
BDTX income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -82442000.00
BDTX income_statement (annual, 2023-12-31) — EBIT: -86460000.00
BDTX income_statement (annual, 2023-12-31) — EBITDA: -86023000.00
BDTX income_statement (annual, 2023-12-31) — Earnings From Equity Interest: 0.00
BDTX cash_flow (annual, 2023-12-31) — Earnings Losses From Equity Investments: 0.00
BDTX cash_flow (annual, 2023-12-31) — End Cash Position: 57044000.00
BDTX cash_flow (annual, 2023-12-31) — Financing Cash Flow: 71932000.00
BDTX cash_flow (annual, 2023-12-31) — Free Cash Flow: -66750000.00
BDTX cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 358000.00
BDTX income_statement (annual, 2023-12-31) — Gain On Sale Of Ppe: 0.00
BDTX balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -27000.00
BDTX income_statement (annual, 2023-12-31) — General And Administrative Expense: 27110000.00
BDTX balance_sheet (annual, 2023-12-31) — Gross PPE: 24509000.00
BDTX income_statement (annual, 2023-12-31) — Interest Income: 1924000.00
BDTX income_statement (annual, 2023-12-31) — Interest Income Non Operating: 1924000.00
BDTX balance_sheet (annual, 2023-12-31) — Invested Capital: 116736000.00
BDTX cash_flow (annual, 2023-12-31) — Investing Cash Flow: 16346000.00
BDTX cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 71850000.00
BDTX balance_sheet (annual, 2023-12-31) — Leases: 2512000.00
BDTX balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 22185000.00
BDTX balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 22185000.00
BDTX balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 17000.00
BDTX cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 71850000.00
BDTX income_statement (annual, 2023-12-31) — Net Income: -82442000.00
BDTX income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -82442000.00
BDTX income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -82442000.00
BDTX income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -82442000.00
BDTX income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -82442000.00
BDTX cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -82442000.00
BDTX income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -82442000.00
BDTX income_statement (annual, 2023-12-31) — Net Interest Income: 1924000.00
BDTX cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 16284000.00
BDTX income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 1924000.00
BDTX balance_sheet (annual, 2023-12-31) — Net PPE: 23710000.00
BDTX cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: 62000.00
BDTX balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 116736000.00
BDTX income_statement (annual, 2023-12-31) — Normalized EBITDA: -86023000.00
BDTX income_statement (annual, 2023-12-31) — Normalized Income: -82442000.00
BDTX cash_flow (annual, 2023-12-31) — Operating Cash Flow: -66717000.00
BDTX cash_flow (annual, 2023-12-31) — Operating Gains Losses: 358000.00
BDTX income_statement (annual, 2023-12-31) — Operating Income: -86460000.00
BDTX income_statement (annual, 2023-12-31) — Operating Revenue: 0.00
BDTX balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 51645557.00
BDTX balance_sheet (annual, 2023-12-31) — Other Current Assets: 2634000.00
BDTX balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -27000.00
BDTX income_statement (annual, 2023-12-31) — Other Gand A: 27110000.00
BDTX income_statement (annual, 2023-12-31) — Other Income Expense: 2094000.00
BDTX cash_flow (annual, 2023-12-31) — Other Non Cash Items: 2814000.00
BDTX balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 823000.00
BDTX income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 2094000.00
BDTX balance_sheet (annual, 2023-12-31) — Other Properties: 21980000.00
BDTX balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 75179000.00
BDTX balance_sheet (annual, 2023-12-31) — Payables: 2324000.00
BDTX balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 16533000.00
BDTX balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
BDTX income_statement (annual, 2023-12-31) — Pretax Income: -82442000.00
BDTX cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 82000.00
BDTX balance_sheet (annual, 2023-12-31) — Properties: 0.00
BDTX cash_flow (annual, 2023-12-31) — Purchase Of Investment: -61887000.00
BDTX cash_flow (annual, 2023-12-31) — Purchase Of PPE: -33000.00
BDTX income_statement (annual, 2023-12-31) — Reconciled Depreciation: 437000.00
BDTX income_statement (annual, 2023-12-31) — Research And Development: 59350000.00
BDTX balance_sheet (annual, 2023-12-31) — Retained Earnings: -417431000.00
BDTX cash_flow (annual, 2023-12-31) — Sale Of Investment: 78171000.00
BDTX cash_flow (annual, 2023-12-31) — Sale Of PPE: 95000.00
BDTX income_statement (annual, 2023-12-31) — Selling General And Administration: 27110000.00
BDTX balance_sheet (annual, 2023-12-31) — Share Issued: 51645557.00
BDTX income_statement (annual, 2023-12-31) — Special Income Charges: 0.00
BDTX cash_flow (annual, 2023-12-31) — Stock Based Compensation: 9604000.00
BDTX balance_sheet (annual, 2023-12-31) — Stockholders Equity: 116736000.00
BDTX balance_sheet (annual, 2023-12-31) — Tangible Book Value: 116736000.00
BDTX income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
BDTX income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
BDTX balance_sheet (annual, 2023-12-31) — Total Assets: 158567000.00
BDTX balance_sheet (annual, 2023-12-31) — Total Capitalization: 116736000.00
BDTX balance_sheet (annual, 2023-12-31) — Total Debt: 25298000.00
BDTX balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 116736000.00
BDTX income_statement (annual, 2023-12-31) — Total Expenses: 86460000.00
BDTX balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 41831000.00
BDTX balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 24533000.00
BDTX balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 22185000.00
BDTX income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -86460000.00
BDTX income_statement (annual, 2023-12-31) — Total Unusual Items: 0.00
BDTX income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 0.00
BDTX balance_sheet (annual, 2023-12-31) — Working Capital: 114388000.00
BDTX income_statement (annual, 2024-12-31) — +Operating Expense: 78781000.00
BDTX income_statement (annual, 2024-12-31) — +Total Revenue: 0.00
BDTX balance_sheet (annual, 2024-12-31) — Accounts Payable: 4007000.00
BDTX balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -1142000.00
BDTX balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 570361000.00
BDTX cash_flow (annual, 2024-12-31) — Amortization Of Securities: -3782000.00
BDTX income_statement (annual, 2024-12-31) — Basic Average Shares: 55028371.00
BDTX income_statement (annual, 2024-12-31) — Basic EPS: -1.27
BDTX cash_flow (annual, 2024-12-31) — Beginning Cash Position: 57044000.00
BDTX balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 22186000.00
BDTX balance_sheet (annual, 2024-12-31) — Capital Stock: 7000.00
BDTX balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 36437000.00
BDTX balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 98575000.00
BDTX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 25547000.00
BDTX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: 16968000.00
BDTX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -62303000.00
BDTX cash_flow (annual, 2024-12-31) — Change In Account Payable: 1683000.00
BDTX cash_flow (annual, 2024-12-31) — Change In Accrued Expense: -756000.00
BDTX cash_flow (annual, 2024-12-31) — Change In Other Current Assets: -249000.00
BDTX cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -3403000.00
BDTX cash_flow (annual, 2024-12-31) — Change In Payable: 1683000.00
BDTX cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 927000.00
BDTX cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 33000.00
BDTX cash_flow (annual, 2024-12-31) — Change In Working Capital: -2692000.00
BDTX cash_flow (annual, 2024-12-31) — Changes In Cash: -19788000.00
BDTX balance_sheet (annual, 2024-12-31) — Common Stock: 7000.00
BDTX balance_sheet (annual, 2024-12-31) — Common Stock Equity: 83285000.00
BDTX cash_flow (annual, 2024-12-31) — Common Stock Issuance: 24494000.00
BDTX cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 0.00
BDTX balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 13162000.00
BDTX balance_sheet (annual, 2024-12-31) — Current Assets: 101176000.00
BDTX balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 3404000.00
BDTX balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 3404000.00
BDTX balance_sheet (annual, 2024-12-31) — Current Liabilities: 20573000.00
BDTX cash_flow (annual, 2024-12-31) — Depreciation: 343000.00
BDTX cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 343000.00
BDTX cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 343000.00
BDTX income_statement (annual, 2024-12-31) — Diluted Average Shares: 55028371.00
BDTX income_statement (annual, 2024-12-31) — Diluted EPS: -1.27
BDTX income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -69676000.00
BDTX income_statement (annual, 2024-12-31) — EBIT: -78781000.00
BDTX income_statement (annual, 2024-12-31) — EBITDA: -78438000.00
BDTX cash_flow (annual, 2024-12-31) — End Cash Position: 37256000.00
BDTX cash_flow (annual, 2024-12-31) — Financing Cash Flow: 25547000.00
BDTX cash_flow (annual, 2024-12-31) — Free Cash Flow: -62303000.00
BDTX cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: -94000.00
BDTX balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 24000.00
BDTX income_statement (annual, 2024-12-31) — General And Administrative Expense: 27469000.00
BDTX balance_sheet (annual, 2024-12-31) — Gross PPE: 21538000.00
BDTX income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 0.00
BDTX income_statement (annual, 2024-12-31) — Interest Income: 2182000.00
BDTX income_statement (annual, 2024-12-31) — Interest Income Non Operating: 2182000.00
BDTX balance_sheet (annual, 2024-12-31) — Invested Capital: 83285000.00
BDTX cash_flow (annual, 2024-12-31) — Investing Cash Flow: 16968000.00
BDTX cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 24494000.00
BDTX cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 0.00
BDTX balance_sheet (annual, 2024-12-31) — Leases: 2512000.00
BDTX balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 18782000.00
BDTX balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 18782000.00
BDTX balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 17000.00
BDTX balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 17000.00
BDTX cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 24494000.00
BDTX cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 0.00
BDTX income_statement (annual, 2024-12-31) — Net Income: -69676000.00
BDTX income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -69676000.00
BDTX income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -69676000.00
BDTX income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -69676000.00
BDTX income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -69676000.00
BDTX cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -69676000.00
BDTX income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -69676000.00
BDTX income_statement (annual, 2024-12-31) — Net Interest Income: 2182000.00
BDTX cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 16874000.00
BDTX income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 2182000.00
BDTX balance_sheet (annual, 2024-12-31) — Net PPE: 20396000.00
BDTX cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: 94000.00
BDTX balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 83285000.00
BDTX income_statement (annual, 2024-12-31) — Normalized EBITDA: -78438000.00
BDTX income_statement (annual, 2024-12-31) — Normalized Income: -69676000.00
BDTX cash_flow (annual, 2024-12-31) — Operating Cash Flow: -62303000.00
BDTX cash_flow (annual, 2024-12-31) — Operating Gains Losses: -94000.00
BDTX cash_flow (quarterly, 2024-12-31) — Operating Gains Losses: -8000.00
BDTX income_statement (annual, 2024-12-31) — Operating Income: -78781000.00
BDTX income_statement (annual, 2024-12-31) — Operating Revenue: 0.00
BDTX balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 56644655.00
BDTX balance_sheet (annual, 2024-12-31) — Other Current Assets: 2601000.00
BDTX balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 24000.00
BDTX income_statement (annual, 2024-12-31) — Other Gand A: 27469000.00
BDTX income_statement (annual, 2024-12-31) — Other Income Expense: 6923000.00
BDTX cash_flow (annual, 2024-12-31) — Other Non Cash Items: 2971000.00
BDTX balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 1068000.00
BDTX income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 6923000.00
BDTX balance_sheet (annual, 2024-12-31) — Other Properties: 19009000.00
BDTX balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 62138000.00
BDTX balance_sheet (annual, 2024-12-31) — Payables: 4007000.00
BDTX balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 17169000.00
BDTX balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
BDTX income_statement (annual, 2024-12-31) — Pretax Income: -69676000.00
BDTX cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 1053000.00
BDTX balance_sheet (annual, 2024-12-31) — Properties: 0.00
BDTX cash_flow (annual, 2024-12-31) — Purchase Of Investment: -122876000.00
BDTX cash_flow (annual, 2024-12-31) — Purchase Of PPE: 0.00
BDTX cash_flow (quarterly, 2024-12-31) — Purchase Of PPE: 0.00
BDTX income_statement (annual, 2024-12-31) — Reconciled Depreciation: 343000.00
BDTX income_statement (annual, 2024-12-31) — Research And Development: 51312000.00
BDTX balance_sheet (annual, 2024-12-31) — Retained Earnings: -487107000.00
BDTX cash_flow (annual, 2024-12-31) — Sale Of Investment: 139750000.00
BDTX cash_flow (annual, 2024-12-31) — Sale Of PPE: 94000.00
BDTX income_statement (annual, 2024-12-31) — Selling General And Administration: 27469000.00
BDTX balance_sheet (annual, 2024-12-31) — Share Issued: 56644655.00
BDTX income_statement (annual, 2024-12-31) — Special Income Charges: 0.00
BDTX cash_flow (annual, 2024-12-31) — Stock Based Compensation: 10627000.00
BDTX balance_sheet (annual, 2024-12-31) — Stockholders Equity: 83285000.00
BDTX balance_sheet (annual, 2024-12-31) — Tangible Book Value: 83285000.00
BDTX income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
BDTX income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
BDTX balance_sheet (annual, 2024-12-31) — Total Assets: 122640000.00
BDTX balance_sheet (annual, 2024-12-31) — Total Capitalization: 83285000.00
BDTX balance_sheet (annual, 2024-12-31) — Total Debt: 22186000.00
BDTX balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 83285000.00
BDTX income_statement (annual, 2024-12-31) — Total Expenses: 78781000.00
BDTX balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 39355000.00
BDTX balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 21464000.00
BDTX balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 18782000.00
BDTX income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -78781000.00
BDTX income_statement (annual, 2024-12-31) — Total Unusual Items: 0.00
BDTX income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
BDTX balance_sheet (annual, 2024-12-31) — Working Capital: 80603000.00
BDTX income_statement (quarterly, 2025-03-31) — +Operating Expense: 15470000.00
BDTX income_statement (quarterly, 2025-03-31) — +Total Revenue: 70000000.00
BDTX balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 2628000.00
BDTX balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -1229000.00
BDTX balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 572093000.00
BDTX cash_flow (quarterly, 2025-03-31) — Amortization Of Securities: -415000.00
BDTX income_statement (quarterly, 2025-03-31) — Basic Average Shares: 56663798.00
BDTX income_statement (quarterly, 2025-03-31) — Basic EPS: 1.00
BDTX cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 37256000.00
BDTX balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 21587000.00
BDTX balance_sheet (quarterly, 2025-03-31) — Capital Stock: 7000.00
BDTX balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 98424000.00
BDTX balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 152400000.00
BDTX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 32000.00
BDTX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 8547000.00
BDTX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 53410000.00
BDTX cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -1379000.00
BDTX cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -2347000.00
BDTX cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 44000.00
BDTX cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -900000.00
BDTX cash_flow (quarterly, 2025-03-31) — Change In Payable: -1379000.00
BDTX cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -3726000.00
BDTX cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -678000.00
BDTX cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -5260000.00
BDTX cash_flow (quarterly, 2025-03-31) — Changes In Cash: 61989000.00
BDTX balance_sheet (quarterly, 2025-03-31) — Common Stock: 7000.00
BDTX balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 141516000.00
BDTX cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 0.00
BDTX balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 10514000.00
BDTX balance_sheet (quarterly, 2025-03-31) — Current Assets: 155679000.00
BDTX balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 3705000.00
BDTX balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 3705000.00
BDTX balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 16847000.00
BDTX cash_flow (quarterly, 2025-03-31) — Depreciation: 87000.00
BDTX cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 87000.00
BDTX cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 87000.00
BDTX income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 57673099.00
BDTX income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.98
BDTX income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 56542000.00
BDTX income_statement (quarterly, 2025-03-31) — EBIT: 54530000.00
BDTX income_statement (quarterly, 2025-03-31) — EBITDA: 54617000.00
BDTX cash_flow (quarterly, 2025-03-31) — End Cash Position: 99245000.00
BDTX cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 32000.00
BDTX cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 53410000.00
BDTX cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of PPE: -13000.00
BDTX balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -19000.00
BDTX income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 4964000.00
BDTX balance_sheet (quarterly, 2025-03-31) — Gross PPE: 20769000.00
BDTX income_statement (quarterly, 2025-03-31) — Interest Income: 595000.00
BDTX income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 595000.00
BDTX balance_sheet (quarterly, 2025-03-31) — Invested Capital: 141516000.00
BDTX cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 8547000.00
BDTX cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 0.00
BDTX balance_sheet (quarterly, 2025-03-31) — Leases: 2512000.00
BDTX balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 17882000.00
BDTX balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 17882000.00
BDTX balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 17000.00
BDTX cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
BDTX income_statement (quarterly, 2025-03-31) — Net Income: 56542000.00
BDTX income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 56542000.00
BDTX income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 56542000.00
BDTX income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 56542000.00
BDTX income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 56542000.00
BDTX cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 56542000.00
BDTX income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 56542000.00
BDTX income_statement (quarterly, 2025-03-31) — Net Interest Income: 595000.00
BDTX cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 8534000.00
BDTX income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 595000.00
BDTX balance_sheet (quarterly, 2025-03-31) — Net PPE: 19540000.00
BDTX cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: 13000.00
BDTX balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 141516000.00
BDTX income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 54617000.00
BDTX income_statement (quarterly, 2025-03-31) — Normalized Income: 56542000.00
BDTX cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 53410000.00
BDTX cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -13000.00
BDTX income_statement (quarterly, 2025-03-31) — Operating Income: 54530000.00
BDTX income_statement (quarterly, 2025-03-31) — Operating Revenue: 70000000.00
BDTX balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 56676716.00
BDTX balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 3279000.00
BDTX balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -19000.00
BDTX income_statement (quarterly, 2025-03-31) — Other Gand A: 4964000.00
BDTX income_statement (quarterly, 2025-03-31) — Other Income Expense: 1417000.00
BDTX cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 769000.00
BDTX balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 1026000.00
BDTX income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 1417000.00
BDTX balance_sheet (quarterly, 2025-03-31) — Other Properties: 18240000.00
BDTX balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 53976000.00
BDTX balance_sheet (quarterly, 2025-03-31) — Payables: 2628000.00
BDTX balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 13142000.00
BDTX balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
BDTX income_statement (quarterly, 2025-03-31) — Pretax Income: 56542000.00
BDTX cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 32000.00
BDTX balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
BDTX cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -23466000.00
BDTX income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 87000.00
BDTX income_statement (quarterly, 2025-03-31) — Research And Development: 10506000.00
BDTX balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -430565000.00
BDTX cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 32000000.00
BDTX cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 13000.00
BDTX income_statement (quarterly, 2025-03-31) — Selling General And Administration: 4964000.00
BDTX balance_sheet (quarterly, 2025-03-31) — Share Issued: 56676716.00
BDTX cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 1700000.00
BDTX balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 141516000.00
BDTX balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 141516000.00
BDTX income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
BDTX income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.21
BDTX balance_sheet (quarterly, 2025-03-31) — Total Assets: 176245000.00
BDTX balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 141516000.00
BDTX balance_sheet (quarterly, 2025-03-31) — Total Debt: 21587000.00
BDTX balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 141516000.00
BDTX income_statement (quarterly, 2025-03-31) — Total Expenses: 15470000.00
BDTX balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 34729000.00
BDTX balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 20566000.00
BDTX balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 17882000.00
BDTX income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 54530000.00
BDTX balance_sheet (quarterly, 2025-03-31) — Working Capital: 138832000.00
BDTX income_statement (quarterly, 2025-06-30) — +Operating Expense: 13420000.00
BDTX income_statement (quarterly, 2025-06-30) — +Total Revenue: 0.00
BDTX balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 771000.00
BDTX balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -1315000.00
BDTX balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 573754000.00
BDTX cash_flow (quarterly, 2025-06-30) — Amortization Of Securities: -423000.00
BDTX income_statement (quarterly, 2025-06-30) — Basic Average Shares: 56803450.00
BDTX income_statement (quarterly, 2025-06-30) — Basic EPS: -0.19
BDTX cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 99245000.00
BDTX balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 20752000.00
BDTX balance_sheet (quarterly, 2025-06-30) — Capital Stock: 7000.00
BDTX balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 29993000.00
BDTX balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 142829000.00
BDTX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -116000.00
BDTX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -59153000.00
BDTX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -9159000.00
BDTX cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -1857000.00
BDTX cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 1815000.00
BDTX cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: 44000.00
BDTX cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -912000.00
BDTX cash_flow (quarterly, 2025-06-30) — Change In Payable: -1857000.00
BDTX cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -42000.00
BDTX cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 105000.00
BDTX cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -805000.00
BDTX cash_flow (quarterly, 2025-06-30) — Changes In Cash: -68428000.00
BDTX balance_sheet (quarterly, 2025-06-30) — Common Stock: 7000.00
BDTX balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 132610000.00
BDTX cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 0.00
BDTX balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 12252000.00
BDTX balance_sheet (quarterly, 2025-06-30) — Current Assets: 146726000.00
BDTX balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 3782000.00
BDTX balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 3782000.00
BDTX balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 16805000.00
BDTX cash_flow (quarterly, 2025-06-30) — Depreciation: 86000.00
BDTX cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 86000.00
BDTX cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 86000.00
BDTX income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 56803450.00
BDTX income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.19
BDTX income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -10561000.00
BDTX income_statement (quarterly, 2025-06-30) — EBIT: -13420000.00
BDTX income_statement (quarterly, 2025-06-30) — EBITDA: -13334000.00
BDTX cash_flow (quarterly, 2025-06-30) — End Cash Position: 30817000.00
BDTX cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -116000.00
BDTX cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -9159000.00
BDTX cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of PPE: -10000.00
BDTX balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -25000.00
BDTX income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 4101000.00
BDTX balance_sheet (quarterly, 2025-06-30) — Gross PPE: 19989000.00
BDTX income_statement (quarterly, 2025-06-30) — Interest Income: 1118000.00
BDTX income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 1118000.00
BDTX balance_sheet (quarterly, 2025-06-30) — Invested Capital: 132610000.00
BDTX cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -59153000.00
BDTX cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 0.00
BDTX balance_sheet (quarterly, 2025-06-30) — Leases: 2512000.00
BDTX balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 16970000.00
BDTX balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 16970000.00
BDTX balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 17000.00
BDTX cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 0.00
BDTX income_statement (quarterly, 2025-06-30) — Net Income: -10561000.00
BDTX income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -10561000.00
BDTX income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -10561000.00
BDTX income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -10561000.00
BDTX income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -10561000.00
BDTX cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -10561000.00
BDTX income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -10561000.00
BDTX income_statement (quarterly, 2025-06-30) — Net Interest Income: 1118000.00
BDTX cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -59163000.00
BDTX income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 1118000.00
BDTX balance_sheet (quarterly, 2025-06-30) — Net PPE: 18674000.00
BDTX cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: 10000.00
BDTX balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 132610000.00
BDTX income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -13334000.00
BDTX income_statement (quarterly, 2025-06-30) — Normalized Income: -10561000.00
BDTX cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -9159000.00
BDTX cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -13000.00
BDTX income_statement (quarterly, 2025-06-30) — Operating Income: -13420000.00
BDTX income_statement (quarterly, 2025-06-30) — Operating Revenue: 0.00
BDTX balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 56886939.00
BDTX balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 3897000.00
BDTX balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -25000.00
BDTX income_statement (quarterly, 2025-06-30) — Other Gand A: 4101000.00
BDTX income_statement (quarterly, 2025-06-30) — Other Income Expense: 1741000.00
BDTX cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 780000.00
BDTX balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 985000.00
BDTX income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 1741000.00
BDTX balance_sheet (quarterly, 2025-06-30) — Other Properties: 17460000.00
BDTX balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 112836000.00
BDTX balance_sheet (quarterly, 2025-06-30) — Payables: 771000.00
BDTX balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 13023000.00
BDTX balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
BDTX income_statement (quarterly, 2025-06-30) — Pretax Income: -10561000.00
BDTX cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: -116000.00
BDTX balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
BDTX cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -89746000.00
BDTX income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 86000.00
BDTX income_statement (quarterly, 2025-06-30) — Research And Development: 9319000.00
BDTX balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -441126000.00
BDTX cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 30583000.00
BDTX cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 10000.00
BDTX income_statement (quarterly, 2025-06-30) — Selling General And Administration: 4101000.00
BDTX balance_sheet (quarterly, 2025-06-30) — Share Issued: 56886939.00
BDTX cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 1777000.00
BDTX balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 132610000.00
BDTX balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 132610000.00
BDTX income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
BDTX income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
BDTX balance_sheet (quarterly, 2025-06-30) — Total Assets: 166385000.00
BDTX balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 132610000.00
BDTX balance_sheet (quarterly, 2025-06-30) — Total Debt: 20752000.00
BDTX balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 132610000.00
BDTX income_statement (quarterly, 2025-06-30) — Total Expenses: 13420000.00
BDTX balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 33775000.00
BDTX balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 19659000.00
BDTX balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 16970000.00
BDTX income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -13420000.00
BDTX balance_sheet (quarterly, 2025-06-30) — Working Capital: 129921000.00
BDTX income_statement (quarterly, 2025-09-30) — +Operating Expense: 10978000.00
BDTX income_statement (quarterly, 2025-09-30) — +Total Revenue: 0.00
BDTX balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 975000.00
BDTX balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -1401000.00
BDTX balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 575626000.00
BDTX cash_flow (quarterly, 2025-09-30) — Amortization Of Securities: -292000.00
BDTX income_statement (quarterly, 2025-09-30) — Basic Average Shares: 56929103.00
BDTX income_statement (quarterly, 2025-09-30) — Basic EPS: -0.15
BDTX cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 30817000.00
BDTX balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 19670000.00
BDTX balance_sheet (quarterly, 2025-09-30) — Capital Stock: 8000.00
BDTX balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 30864000.00
BDTX balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 135503000.00
BDTX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 134000.00
BDTX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 8590000.00
BDTX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -7850000.00
BDTX cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 204000.00
BDTX cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: -1464000.00
BDTX cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 44000.00
BDTX cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -934000.00
BDTX cash_flow (quarterly, 2025-09-30) — Change In Payable: 204000.00
BDTX cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -1260000.00
BDTX cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 475000.00
BDTX cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -1675000.00
BDTX cash_flow (quarterly, 2025-09-30) — Changes In Cash: 874000.00
BDTX balance_sheet (quarterly, 2025-09-30) — Common Stock: 8000.00
BDTX balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 126152000.00
BDTX cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 0.00
BDTX balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 10936000.00
BDTX balance_sheet (quarterly, 2025-09-30) — Current Assets: 138992000.00
BDTX balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 3634000.00
BDTX balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 3634000.00
BDTX balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 15545000.00
BDTX cash_flow (quarterly, 2025-09-30) — Depreciation: 86000.00
BDTX cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 86000.00
BDTX cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 86000.00
BDTX income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 56929103.00
BDTX income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.15
BDTX income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -8498000.00
BDTX income_statement (quarterly, 2025-09-30) — EBIT: -10978000.00
BDTX income_statement (quarterly, 2025-09-30) — EBITDA: -10892000.00
BDTX cash_flow (quarterly, 2025-09-30) — End Cash Position: 31691000.00
BDTX cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 134000.00
BDTX cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -7850000.00
BDTX cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: 0.00
BDTX cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of PPE: -1000.00
BDTX balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 142000.00
BDTX income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 3541000.00
BDTX balance_sheet (quarterly, 2025-09-30) — Gross PPE: 19198000.00
BDTX income_statement (quarterly, 2025-09-30) — Interest Income: 1164000.00
BDTX income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 1164000.00
BDTX balance_sheet (quarterly, 2025-09-30) — Invested Capital: 126152000.00
BDTX cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 8590000.00
BDTX cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 0.00
BDTX balance_sheet (quarterly, 2025-09-30) — Leases: 2512000.00
BDTX balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 16036000.00
BDTX balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 16036000.00
BDTX balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 17000.00
BDTX cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
BDTX income_statement (quarterly, 2025-09-30) — Net Income: -8498000.00
BDTX income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -8498000.00
BDTX income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -8498000.00
BDTX income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -8498000.00
BDTX income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -8498000.00
BDTX cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -8498000.00
BDTX income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -8498000.00
BDTX income_statement (quarterly, 2025-09-30) — Net Interest Income: 1164000.00
BDTX cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 8589000.00
BDTX income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 1164000.00
BDTX balance_sheet (quarterly, 2025-09-30) — Net PPE: 17797000.00
BDTX cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: 1000.00
BDTX balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 126152000.00
BDTX income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -10892000.00
BDTX income_statement (quarterly, 2025-09-30) — Normalized Income: -8498000.00
BDTX cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -7850000.00
BDTX cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -1000.00
BDTX income_statement (quarterly, 2025-09-30) — Operating Income: -10978000.00
BDTX income_statement (quarterly, 2025-09-30) — Operating Revenue: 0.00
BDTX balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 56943413.00
BDTX balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 3489000.00
BDTX balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 142000.00
BDTX income_statement (quarterly, 2025-09-30) — Other Gand A: 3541000.00
BDTX income_statement (quarterly, 2025-09-30) — Other Income Expense: 1316000.00
BDTX cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 791000.00
BDTX balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 944000.00
BDTX income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 1316000.00
BDTX balance_sheet (quarterly, 2025-09-30) — Other Properties: 16669000.00
BDTX balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 104639000.00
BDTX balance_sheet (quarterly, 2025-09-30) — Payables: 975000.00
BDTX balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 11911000.00
BDTX balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
BDTX income_statement (quarterly, 2025-09-30) — Pretax Income: -8498000.00
BDTX cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 134000.00
BDTX balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
BDTX cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -14911000.00
BDTX income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 86000.00
BDTX income_statement (quarterly, 2025-09-30) — Research And Development: 7437000.00
BDTX balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -449624000.00
BDTX cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 23500000.00
BDTX cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 1000.00
BDTX income_statement (quarterly, 2025-09-30) — Selling General And Administration: 3541000.00
BDTX balance_sheet (quarterly, 2025-09-30) — Share Issued: 56943413.00
BDTX cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 1739000.00
BDTX balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 126152000.00
BDTX balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 126152000.00
BDTX income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
BDTX income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
BDTX balance_sheet (quarterly, 2025-09-30) — Total Assets: 157733000.00
BDTX balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 126152000.00
BDTX balance_sheet (quarterly, 2025-09-30) — Total Debt: 19670000.00
BDTX balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 126152000.00
BDTX income_statement (quarterly, 2025-09-30) — Total Expenses: 10978000.00
BDTX balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 31581000.00
BDTX balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 18741000.00
BDTX balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 16036000.00
BDTX income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -10978000.00
BDTX balance_sheet (quarterly, 2025-09-30) — Working Capital: 123447000.00
BDTX income_statement (annual, 2025-12-31) — +Operating Expense: 50130000.00
BDTX income_statement (quarterly, 2025-12-31) — +Operating Expense: 10262000.00
BDTX income_statement (annual, 2025-12-31) — +Total Revenue: 70000000.00
BDTX income_statement (quarterly, 2025-12-31) — +Total Revenue: 0.00
BDTX balance_sheet (annual, 2025-12-31) — Accounts Payable: 579000.00
BDTX balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 579000.00
BDTX balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -1228000.00
BDTX balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -1228000.00
BDTX balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 576842000.00
BDTX balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 576842000.00
BDTX cash_flow (annual, 2025-12-31) — Amortization Of Securities: -1279000.00
BDTX cash_flow (quarterly, 2025-12-31) — Amortization Of Securities: -149000.00
BDTX income_statement (annual, 2025-12-31) — Basic Average Shares: 56868111.00
BDTX income_statement (quarterly, 2025-12-31) — Basic Average Shares: 57090948.00
BDTX income_statement (annual, 2025-12-31) — Basic EPS: 0.39
BDTX income_statement (quarterly, 2025-12-31) — Basic EPS: -0.27
BDTX cash_flow (annual, 2025-12-31) — Beginning Cash Position: 37256000.00
BDTX cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 31691000.00
BDTX balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 18781000.00
BDTX balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 18781000.00
BDTX balance_sheet (annual, 2025-12-31) — Capital Stock: 8000.00
BDTX balance_sheet (quarterly, 2025-12-31) — Capital Stock: 8000.00
BDTX balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 20990000.00
BDTX balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 20990000.00
BDTX balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 128652000.00
BDTX balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 128652000.00
BDTX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -146000.00
BDTX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -196000.00
BDTX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -44905000.00
BDTX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -2889000.00
BDTX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 29614000.00
BDTX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -6787000.00
BDTX cash_flow (annual, 2025-12-31) — Change In Account Payable: -3428000.00
BDTX cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -396000.00
BDTX cash_flow (annual, 2025-12-31) — Change In Accrued Expense: -1414000.00
BDTX cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 582000.00
BDTX cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 176000.00
BDTX cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 44000.00
BDTX cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -3713000.00
BDTX cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -967000.00
BDTX cash_flow (annual, 2025-12-31) — Change In Payable: -3428000.00
BDTX cash_flow (quarterly, 2025-12-31) — Change In Payable: -396000.00
BDTX cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -4842000.00
BDTX cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 186000.00
BDTX cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -349000.00
BDTX cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -251000.00
BDTX cash_flow (annual, 2025-12-31) — Change In Working Capital: -8728000.00
BDTX cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -988000.00